Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Comparison of Metolazone Versus Chlorothiazide for Acute Decompensated Heart Failure With Diuretic Resistance

NCT03574857 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

NCT NCT03574857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03574857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Comparison of Metolazone Versus Chlorothiazide for Acute Decompensated Heart Failure With Diuretic Resistance
Lead sponsor
University of Virginia
Phase
Phase 4
Overall status
Terminated
Start date
June 1, 2018
Completion date
January 1, 2021
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, heart failure, heart failure acute, heart failure with reduced ejection fraction